Shin Mineishi

Shin Mineishi

UNVERIFIED PROFILE

Are you Shin Mineishi?   Register this Author

Register author
Shin Mineishi

Shin Mineishi

Publications by authors named "Shin Mineishi"

Are you Shin Mineishi?   Register this Author

74Publications

1493Reads

12Profile Views

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance.

Front Immunol 2019 1;10:93. Epub 2019 Feb 1.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367268PMC
February 2019

Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML.

Int J Hematol 2018 Sep 14;108(3):348-350. Epub 2018 Mar 14.

Department of Medicine, Division of Hematology/Oncology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-018-2431-5DOI Listing
September 2018

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 01;378(1):35-47

From the Duke University Medical Center (K.M.S., O.C., E.W.S.C.) and RTI International (D.W.), Durham, and Rho Federal Systems Division, Chapel Hill (L.K.-E., A.P., B.E., S.C.) - all in North Carolina; National Institute of Allergy and Infectious Diseases, Bethesda, MD (E.A.G., B.W., L.M.G., J.S.G.); Colorado Blood Cancer Institute, Denver (P.A.M., R.A.N.); University of Texas McGovern Medical School (M.D.M.) and M.D. Anderson Cancer Center (C.H.) - both in Houston; Vanderbilt University, Nashville (L.J.C., K.P.); University of Michigan, Ann Arbor (D.K., J.R.S.); Case Western Reserve University and University Hospitals, Cleveland (R.J.F.); University of Alabama, Birmingham (S.M.); Boston University, Boston (R.W.S.); University of Virginia, Charlottesville (K.B.); University of Washington (M.H.W., D.E.F.) and the Fred Hutchinson Cancer Research Center (G.E.G., S.H.) - both in Seattle; University of California, Los Angeles, Los Angeles (J.G., S.K., D.E.F.); City of Hope National Medical Center, Duarte, CA (S.F.); Medical University of South Carolina, Charleston (R.M.S.); Mayo Clinic, Scottsdale, AZ (L.G.); University of Calgary, Calgary, AB, Canada (J.S., S.L.); Washington University, St. Louis (R.B.); Medical College of Wisconsin, Milwaukee (M.E.C., C.K.-T.); Ottawa Hospital Research Institute, Ottawa (C.B.); University of Pittsburgh, Pittsburgh (T.M., R.T.D.); and University of Toledo Medical Center, Toledo, OH (M.B.K.).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846574PMC
January 2018

Hematopoietic stem cell transplantation in the era of molecular targeted therapy.

Authors:
Shin Mineishi

Rinsho Ketsueki 2017;58(10):2135-2140

Blood and Marrow Transplant Program, Penn State Hershey Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.58.2135DOI Listing
December 2017

Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation.

Am J Case Rep 2017 Mar 10;18:246-250. Epub 2017 Mar 10.

Blood and Marrow Transplantation and Cellular Therapy Program, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358837PMC
http://dx.doi.org/10.12659/ajcr.899687DOI Listing
March 2017

Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation.

Am J Case Rep 2017 Mar 10;18:246-250. Epub 2017 Mar 10.

Blood and Marrow Transplantation and Cellular Therapy Program, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358837PMC
http://dx.doi.org/10.12659/ajcr.899687DOI Listing
March 2017

Update on stem cell transplantation for acute leukemias.

Authors:
Shin Mineishi

Rinsho Ketsueki 2016 ;57(10):2218-2223

Blood and Marrow Transplant Program, Penn State Hershey Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.57.2218DOI Listing
February 2017

Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation.

Am J Case Rep 2017 Mar 10;18:246-250. Epub 2017 Mar 10.

Blood and Marrow Transplantation and Cellular Therapy Program, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358837PMC
http://dx.doi.org/10.12659/ajcr.899687DOI Listing
March 2017

Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.

Blood 2016 06 3;127(25):3270-80. Epub 2016 May 3.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA; Department of Microbiology and Immunology, Temple University, Philadelphia, PA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-05-644476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920025PMC
June 2016

Reply to a note on the magnitude of hazard ratios.

Cancer 2016 Apr 16;122(8):1299-300. Epub 2016 Feb 16.

Division of Hematology and Oncology Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29923DOI Listing
April 2016

Acute myofascitis as a manifestation of chronic graft-versus-host disease.

Muscle Nerve 2016 Feb 26;53(2):327-9. Epub 2015 Nov 26.

Department of Internal Medicine, Division of Hematology and Oncology University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.24937DOI Listing
February 2016

Nonbiological factors affecting survival in younger patients with acute myeloid leukemia.

Cancer 2015 Nov 14;121(21):3877-84. Epub 2015 Sep 14.

Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29436DOI Listing
November 2015

Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia.

Leuk Lymphoma 2015 Jun 8;56(6):1626-35. Epub 2015 Jan 8.

Division of Hematology and Oncology, BMT and CT Program, Department of Internal Medicine, UAB Hosptial, University of Alabama at Birmingham Comprehensive Cancer Center , Birmingham, AL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.974041DOI Listing
June 2015

State-of-the-art acute and chronic GVHD treatment.

Int J Hematol 2015 May 12;101(5):452-66. Epub 2015 Apr 12.

Division of Hematology and Oncology, University of Alabama at Birmingham (UAB), 1802 6th Ave South, NP 2562, Birmingham, AL, 35294-3300, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1785-1DOI Listing
May 2015

Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"?

JAMA 2015 Feb;313(6):571-2

Blood and Marrow Transplantation & Cell Therapy Program, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.8DOI Listing
February 2015

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

J Clin Oncol 2014 Aug 30;32(22):2365-72. Epub 2014 Jun 30.

Edmund K. Waller and Wayne A.C. Harris, Emory University, Atlanta, GA; Brent R. Logan, Medical College of Wisconsin, Milwaukee, WI; Steven M. Devine, Ohio State University, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Shin Mineishi, University of Alabama at Birmingham, Birmingham, AL; John M. McCarty, Medical College of Virginia, Richmond, VA; Corina E. Gonzalez, Georgetown University Hospital, Washington, DC; Thomas R. Spitzer, Massachusetts General Hospital, Boston, MA; Oleg I. Krijanovski, Sutter East Bay Medical Foundation, Berkeley, CA; Michael L. Linenberger and Ann Woolfrey, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan Howard and Dennis L. Confer, National Marrow Donor Program, Minneapolis, MN; Juan Wu, EMMES Corporation, Rockville, MD; and Claudio Anasetti, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180368PMC
August 2014

Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2012 Jul 10;18(7):1044-54. Epub 2011 Dec 10.

Blood and Marrow Stem Cell Transplantation Program, Division of Hematology/Oncology, Department of Pediatrics, University of Michigan Medical Center,1500 E.Medical Center Drive, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.11.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462521PMC
July 2012

Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.

J Clin Oncol 2009 Oct 8;27(30):5015-22. Epub 2009 Sep 8.

Comprehensive Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI 48109-5936, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.5370DOI Listing
October 2009

Reduced-intensity stem cell transplantation for hematological malignancies: current status and the future.

Curr Stem Cell Res Ther 2007 May;2(2):149-62

Blood and Marrow Transplantation Program, University of Michigan, Comprehensive Cancer Center, MI 48109-0914, USA.

View Article

Download full-text PDF

Source
May 2007

An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning.

Transplantation 2005 Nov;80(9):1145-52

Pharmacology Division, National Cancer Center Research Institute, Tokyo, and Department of Gastroenterology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.tp.0000183289.79693.3dDOI Listing
November 2005

Graft-versus-host disease in mini-transplant.

Leuk Lymphoma 2004 Oct;45(10):1969-80

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-5505, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1042819042000219511DOI Listing
October 2004

[Immunobiology of mini-transplant].

Authors:
Shin Mineishi

Nihon Rinsho 2003 Sep;61(9):1489-94

Hematopoietic Stem Cell Transplant Program, Vanderbilt University Medical Center, USA.

View Article

Download full-text PDF

Source
September 2003

[Mini-transplant from a matched unrelated donor].

Authors:
Shin Mineishi

Nihon Rinsho 2003 Sep;61(9):1561-4

Hematopoietic Stem Cell Transplant Program, Vanderbilt University Medical Center, USA.

View Article

Download full-text PDF

Source
September 2003

[Future directions of mini-transplant].

Authors:
Shin Mineishi

Nihon Rinsho 2003 Sep;61(9):1655-7

Hematopoietic Stem Cell Transplant Program, Vanderbilt University Medical Center, USA.

View Article

Download full-text PDF

Source
September 2003

[Mini-transplantation].

Authors:
Shin Mineishi

Nihon Naika Gakkai Zasshi 2003 Apr;92(4):677-83

View Article

Download full-text PDF

Source
April 2003

[Mini-transplant as an immunotherapy].

Authors:
Shin Mineishi

Rinsho Ketsueki 2002 May;43(5):357-9

View Article

Download full-text PDF

Source
May 2002